Australien - engelska - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - metronidazole, quantity: 7.5 mg/g - gel - excipient ingredients: carbomer 940; disodium edetate; methyl hydroxybenzoate; propyl hydroxybenzoate; propylene glycol; sodium hydroxide; purified water - treatment of inflammatory papules, pustules and erythema of rosacea.

Singapore - engelska - HSA (Health Sciences Authority)

galderma singapore private limited - clobetasol propionate 0.05% - solution - clobetasol propionate 0.05% 0.05% w/w

Singapore - engelska - HSA (Health Sciences Authority)

galderma singapore private limited - metronidazole - gel - metronidazole 0.75%

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

galderma (uk) ltd - adapalene - cutaneous gel - 1mg/1gram

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

galderma (uk) ltd - adapalene - cutaneous cream - 1mg/1gram

Australien - engelska - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - 46206 - skin moisturizing/barrier dressing - provides moisture. used to alleviate conditions such as dry, irritated, flaky or itchy skin. alleviates the symptoms of eczema. helps restore skin barrier

Australien - engelska - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - 47377 - skin exfoliant, professional - intended to prepare the skin for the treatment with metvix cream.

USA - engelska - NLM (National Library of Medicine)

galderma laboratories, l.p. - botulinum toxin type a (unii: e211kpy694) (botulinum toxin type a - unii:e211kpy694) - botulinum toxin type a 300 u - dysport is indicated for the treatment of cervical dystonia in adults. dysport is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with procerus and corrugator muscle activity in adults less than 65 years of age. dysport is indicated for the treatment of spasticity in patients 2 years of age and older. dysport is contraindicated in patients with: - known hypersensitivity to any botulinum toxin products, cow's milk protein, or to any of the components in the formulation [see warnings and precautions (5.3)] .  this product may contain trace amounts of cow's milk protein [see description (11)] . - infection at the proposed injection site(s). risk summary there are no adequate and well-controlled clinical studies with dysport in pregnant women. dysport should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. dysport produced embryo-fetal toxicity in relation to maternal toxicity when given to pregn

Irland - engelska - HPRA (Health Products Regulatory Authority)

galderma international - metronidazole - cream - 7.5 milligram(s)/gram - other chemotherapeutics; metronidazole

Irland - engelska - HPRA (Health Products Regulatory Authority)

galderma international - metronidazole - gel - 7.5 milligram(s)/gram - other chemotherapeutics; metronidazole